2023
REALITY EQUITY
REALITY DEBT
REALITY GERMANY
We'll get back to you ASAP
REALITY Equity Funds acquire, develop, and manage strategic properties that positively impact the Israeli real estate landscape.
We master in identifying unique assets with significant value-add potential, repurposing white elephants, rezoning land use, and enhancing operational performance that ultimately maximize their value and returns.
Our diversified portfolios cover all real estate sectors in Israel including residential, commercial, offices, industrial, logistics, hospitality, public spaces, and mixed-use properties nationwide.
With its close collaboration with national and local governments and consistent performance, REALITY is positioned as one of the key drivers of Israeli real estate supply and value.
Founded
2008
AUM (Active Funds)
$2.5B
Strategy
Asset Type
2023
2019 22 Assets
2015 10 Assets
2012 7 Assets
2008 10 Assets
REALITY Debt offers real estate developers tailor-made financing solutions for all types of properties in Israel.
We offer flexible terms and personal guidance for every stage of the real estate lifecycle. Our financing options include advanced solutions for acquisitions, improvements, construction and promoting projects, including urban renewal projects as well as bridge loans, mezzanine financing and equity financing.
Financing is offered for a wide range of real estate projects including residential, commercial, logistics, mixed-use and more.
Founded
2021
Fund Size
$350m
Strategy
Asset Type
REALITY Germany invests in stable income-producing commercial properties anchored by Germany’s
leading brands.
We acquire, manage, lease, and develop centrally-located properties that consistently deliver sustainable and attractive returns.
Our portfolio includes grocery-anchored neighborhood commercial centers that provide everyday essential goods and services to the local population, office spaces occupied by top-tier companies and government, as well as last-mile logistics.
Founded
2017
AUM
$250m
Strategy
Asset Type
REALITY Plus invests across market opportunities aligned with strategic importance to us and our stakeholders.
Monitoring global trends, we identify vectors for growth that will enhance the value of our business and support our vision for the future of real estate.
REALITY PropTech invests in early-stage ventures that
fundamentally
change the real estate market.
We help game-changing startups accelerate their journey to scale, by bridging the gap between the real-world industry and disruptive innovation.
Our portfolio companies benefit from a unique network and market access, as well as ongoing operational and professional support.
REALITY is collaborating with Bar-Ilan University
to develop
the leaders of tomorrow.
The “Rom Program” is a real estate track for BA students that connects academia and industry. The program combines academic studies in real estate, land appraisal and urban planning with mentorship, skills and practical experiences that support students’ career journey.
We’re happy to share our experience and knowledge, inspire young leaders, and shape the next-generation talent pipeline to meet the industry’s demand for professional human capital.
REALITY manages investments in the farmland real estate sector
on behalf
of one of the largest institutions in Israel.
Using our long-term strategy, we invest in a diversified portfolio of agricultural lands with attractive risk-adjusted returns, meeting our client’s investment objectives.
As the global population increases and food demand grows, farmland offers promising investment opportunities with a hedge against inflation as well as a positive environmental impact.
“Advot” aims to improve patients’ quality of life by providing access to integrative medicine across the public health system in Israel.
Working alongside hospital professionals and caregivers, we provide each health center with targeted grants and the support needed to facilitate integrative care on-site. By raising awareness, equipping departments with therapies and services, supporting medical research, and training medical staff, we contribute to better care that meets patients’ needs.
